




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
放射粒子組織間植入治療惡性腫瘤第1頁/共45頁Brachytherapy1898年居里夫人發(fā)現(xiàn)鐳1905年即進(jìn)行了第1例鐳針插管治療1930年P(guān)aterson及Parker建立了曼切斯特(Manchester)系統(tǒng)1935年小居里夫婦發(fā)現(xiàn)了人工放射性同位素80年代中期,現(xiàn)代近距離治療迅速發(fā)展第2頁/共45頁生物學(xué)優(yōu)勢(外放療相比)腫瘤局部治療的持續(xù)時(shí)間長放射治療的劑量較低對(duì)周圍正常組織的損傷小對(duì)腫瘤細(xì)胞的殺傷力強(qiáng)
第3頁/共45頁ImplantradioactiveseedsintotumorsEmitcontinueouslowenergyγraysInjuryoftissuesandcellsCelldeathandmutationleadingtocancerInteractwithbiomacromolecule第4頁/共45頁AnimalexperimentClinicalresearch第5頁/共45頁HumanpancreaticcancerSw1990cellBABL/cwasinoculatedintothedorsalsideofrightlowerextremityinguinalregionofnudemicePassagedfor3timssubcutaneously,initiatetheexperimentsaftertumorformationwasstablizedExperimentaldesign第6頁/共45頁
SubcutaneouspancreaticcancerxenograftinnudemiceSeedimplantationgroupControlgroupExperimentalmethod第7頁/共45頁Changeofxenograftvolumeinnudemice第8頁/共45頁Comparisonoftumorinhibitionrate第9頁/共45頁第10頁/共45頁ObviousliquefactionnecrosiscanbeseeninthecenteralareaofExperimentalgrouptumor,therearesparsecellsaroudthenecrosisarea(×100)HE
stainingThereisnoorlittlenecrosisareaincenterofcontrolgrouptumor,therearemultipletumorcells(×100)第11頁/共45頁ExperimentalgrouppositiveTK1stainingcellsareexiguous(×200)ControlgrouppositiveTK1stainingcellsareabundent(×200)HE
staining
第12頁/共45頁第13頁/共45頁碘-125放射粒子組織間植入治療屬放射治療,對(duì)周圍正常器官組織無明顯放射損傷裸鼠移植瘤組織植入碘-125粒子后,實(shí)驗(yàn)組心、肺、肝、腎、脾臟外觀大致正常,病理檢查未見明顯放射性炎癥表現(xiàn)
Preliminaryresult第14頁/共45頁ZM.WangMD,ShanghaiRuijinHospitalIntroductionPancreaticcancerisadevastatingdiseaseandtheprognosisremainspoorFewpatientsareeligibleforcurativesurgicalresectionAlternativetherapeuticoptionsareindemand第15頁/共45頁Traditionaltherapyvs.Externalirradiationtherapy
vs.percutaneousseedimplantationZM.WangMD,ShanghaiRuijinHospital第16頁/共45頁ExternalirradiationtherapywasregardedasinsensitivetopancreaticcancerandassociatedwithmoresystemicsideeffectsRadioactiveiodine-125seedimplantationhasminimalsurgicaltraumaandfewcomplications
Themostcommonlyusedisotopeisiodine-125125IplacementwasroutinelyusedatourinstitutionforrecurrenttumorsatvarioussitesTheaimofthisstudywastotestitsfeasibilityforpancreaticlesions
CurrentControversies第17頁/共45頁
11thIO2010,May
23Methodsandmaterials
PatientpopulationDecember2004toAugust2007,31consecutivepatientswereincludedinthisprospective,nonrandomizedstudy
PatientswerediagnosedbyCTorMRIwithhistologicalconfirmationofthediagnosisbyFNAAllpatientsenrolleddisplayedcontraindicationstosurgeryorhadrejectedsurgicaltreatmentduetopersonalreasons
第18頁/共45頁ZM.WangMD,ShanghaiRuijinHospitalMethodsandmaterials
Thetotalvolumeofeachtumorwascalculatedwiththetreatmentplanningsystem(TPS)beforeimplantationTheexpectednumberofimplantedseedwascalculatedaccordingtothemodifiedlevelformulaPatientswerekeptinourradiooncology/interventionalwardwithanusualstayof4fulldays第19頁/共45頁Methodsandmaterials
Clinicalbenefitresponsewasderivedfrommeasurementofpain,functionalimpairmentandweightlossPatientswereexaminedbyCTaftertheoperationResponseratewasdefinedasthesumofCRandPRLocaltumorcontrolwasdefinedastheabsenceoftumorprogression(SD+PR+CR)第20頁/共45頁Methodsandmaterials
10patientsreceivedconcurrentchemotherapywitharterialinfusionofgemcitabinand5-fluorouracil(5-Fu)ChemotherapywasinitiatedoneweekafterandrepeateduptofourcyclesFollow-upvisitsat1month,3month,andevery3monthsforclinicalexamination,bloodsampling,andCTexaminationZM.WangMD,ShanghaiRuijinHospital第21頁/共45頁適應(yīng)癥實(shí)體瘤(如前列腺癌)的根治性治療實(shí)體瘤術(shù)后殘余組織的預(yù)防性治療轉(zhuǎn)移性腫瘤病灶或術(shù)后孤立性腫瘤轉(zhuǎn)移灶而失去手術(shù)價(jià)值者無法手術(shù)的原發(fā)腫瘤的姑息性治療第22頁/共45頁禁忌證
放射性治療不宜(如血液病等)及有麻醉禁忌等病灶范圍廣泛惡液質(zhì)、全身衰竭腫瘤部位有活動(dòng)性出血、壞死或潰瘍嚴(yán)重糖尿病第23頁/共45頁Iodine-125TherapyinAdvancedPancreaticCancerResultsChangeofKarnofskyphysicalscore%(cases)Karnofskyscore
1009080706050Pre-op0(0/31)3.2(1/31)9.7(3/31)
41.9(13/31)
35.5(11/31)
9.7(3/31)Post-op0(0/31)48.4(15/31)
16.1(5/31)
9.7(3/31)
19.4(6/31)
6.4(2/31)
第24頁/共45頁ResultsChangeofpainscore%(cases)Iodine-125TherapyinAdvancedPancreaticCancerNoPain(%)MildPain(%)ModeratePain(%)SeverePain(%)Pre-op6.5(2/31)22.5(7/31)
32.3(10/31)
38.7(12/31)
Post-op38.7(12/31)
32.3(10/31)
16.1(5/31)
12.9(4/31)
第25頁/共45頁ResultsOverallrespondingrate(CR+PR)=61.3%Localtumorcontrolratewas90.3%Mediansurvivaltimeforthewholegroupwas10.31monthsMediansurvivaltimeforpureseedsimplantation(21cases)was7monthsmediansurvivaltimefordrug-seedscombinedwas11month第26頁/共45頁P(yáng)re-implantCTscan(Caseone)
ZM.WangMD,ShanghaiRuijinHospital第27頁/共45頁P(yáng)ost-implantCTscan
ZM.WangMD,ShanghaiRuijinHospital第28頁/共45頁P(yáng)re-implantCTscan(CaseTwo)
第29頁/共45頁術(shù)后CT掃描術(shù)中穿刺碘粒子植入Post-implantCTscan第30頁/共45頁P(yáng)ost-implantCTscan第31頁/共45頁病例2男性76歲
胰腺癌(胰體尾部)Pre-implantCTscan(CaseThree)
第32頁/共45頁術(shù)后CT掃描Post-implantCTscan第33頁/共45頁P(yáng)re-implantCTscan(CaseFour)
第34頁/共45頁P(yáng)ost-implantCTscan
術(shù)后CT二維重建第35頁/共45頁P(yáng)ost-implantCTscan第36頁/共45頁ComplicationsNoseriouscomplicationsencountered2seedsofradioactive125Ifoundtomigratetoliverin2patientsLeukopeniaandrenalfunctionimpairmentwerefoundin4patientsofdrug-seedscombinationgroupIodine-125TherapyinadvancedPancreaticCancer第37頁/共45頁DiscussionPercutaneousimage-guidedseedimplantationhasattractedincreasingattentionExtensiveexperienceswiththistechniquehadbeencollectedtargetingliverandlungmalignanciesThemostcommonlyusedisotopeis125I,and125IplacementhasbecomearoutinetreatmentforrecurrenttumorsatvarioussitesinourinstitutionZM.WangMD,ShanghaiRuijinHospital第38頁/共45頁TechnicalpointsduringtheprocedurePatientsfastedfor24hoursEnsuresteadybreathmovementduringtheprocedurePancreaticsecretionwasinhibitedTransgressstomachissaferthanintestine,avoidingcolonespeciallywhenusinglarge-boreneedlesForpatientswithjaundice,doPTCDfirstImmediateCTscanpostimplantationwasdonetoverifythedistributionoftheseedsZM.WangMD,ShanghaiRuijinHospital第39頁/共45頁Drug-seedscombinedtherapyThereisdatasuggeststhatlocalcontrolratescanbeenhancedbytheadditionofchemotherapyInourstudythemediansurvivaltimebetweenthetwogroupsreachedstatasticallysignificantandencouragedfurtherevaluationZ
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 鋼材寄存合同范本
- 廣告代理投放合作協(xié)議
- 區(qū)塊鏈技術(shù)應(yīng)用合作協(xié)議
- 好玩的游戲(教學(xué)設(shè)計(jì))-2024-2025學(xué)年一年級(jí)上冊數(shù)學(xué)北師大版2024
- 《范進(jìn)中舉》 京劇情景教學(xué)設(shè)計(jì)-2024-2025學(xué)年統(tǒng)編版語文九年級(jí)上冊
- 2025至2030年中國蒸汽輸送管數(shù)據(jù)監(jiān)測研究報(bào)告
- Unit 3 Reading1 教學(xué)設(shè)計(jì) 2024-2025學(xué)年譯林版(2024)七年級(jí)英語上冊
- 2025年地礦地震儀器合作協(xié)議書
- 2025年高溫銀漿項(xiàng)目可行性研究報(bào)告
- 2025至2030年中國深層凈白保濕乳液數(shù)據(jù)監(jiān)測研究報(bào)告
- 道路建筑材料電子教案(全)
- 《一頁紙項(xiàng)目管理》中文模板
- 《淡水養(yǎng)殖基礎(chǔ)知識(shí)》
- 英語演講-機(jī)器人發(fā)展
- 黃河流域生態(tài)保護(hù)和高質(zhì)量發(fā)展知識(shí)競賽試題及答案(共52題)
- 1、1~36號(hào)元素電子排布式、排布圖
- advantrol-pro v2.70學(xué)習(xí)版系統(tǒng)組態(tài)使用手冊
- 職業(yè)院校技能大賽沙盤模擬企業(yè)經(jīng)營賽項(xiàng)規(guī)程
- 職業(yè)衛(wèi)生調(diào)查表
- GB/T 11982.1-2005聚氯乙烯卷材地板第1部分:帶基材的聚氯乙烯卷材地板
- GB/T 10046-2018銀釬料
評(píng)論
0/150
提交評(píng)論